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Telomeres are nucleoprotein complexes comprised of tandem arrays of repetitive DNA 
sequence that serve to protect chromosomal termini from inappropriate degradation, as 
well as to prevent these natural DNA ends from being recognized as broken DNA (dou-
ble-strand breaks) and triggering of inappropriate DNA damage responses. Preservation 
of telomere length requires telomerase, the specialized reverse transcriptase capable of 
maintaining telomere length via template-mediated addition of telomeric repeats onto the 
ends of newly synthesized chromosomes. Loss of either end-capping function or telomere 
length maintenance has been associated with genomic instability or senescence in a
variety of settings; therefore, telomeres and telomerase have well-established connec-
tions to cancer and aging. It has long been recognized that oxidative stress promotes 
shortening of telomeres, and that telomerase activity is a radiation-inducible function.
However, the effects of ionizing radiation (IR) exposure on telomeres per se are much less 
well understood and appreciated. To gain a deeper understanding of the roles, telomeres 
and telomerase play in the response of human cells to IRs of different qualities, we tracked 
changes in telomeric end-capping function, telomere length, and telomerase activity in 
panels of mammary epithelial and hematopoietic cell lines exposed to low linear energy 
transfer (LET) gamma(γ)-rays or high LET, high charge, high energy (HZE) particles, deliv-
ered either acutely or at low dose rates. In addition to demonstrating that dysfunctional 
telomeres contribute to IR-induced mutation frequencies and genome instability, we reveal 
non-canonical roles for telomerase, in that telomerase activity was required for IR-induced 
enrichment of mammary epithelial putative stem/progenitor cell populations, a finding also 
suggestive of cellular reprograming. Taken together, the results reported here establish 
the critical importance of telomeres and telomerase in the radiation response and, as
such, have compelling implications not only for accelerated tumor repopulation following 
radiation therapy but also for carcinogenic potential following low dose exposures as well, 
including those of relevance to spaceflight-associated galactic cosmic radiations.
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inTrODUcTiOn
Telomeres, protective features of chromosomal termini 
composed of tandem arrays of repetitive G/C-rich sequence 
(5′-TTAGGG-3′ in vertebrates), end in a 3′ single-stranded 
overhang and are associated with a host of proteins collectively 
termed “shelterin” (1, 2). Telomere-specific binding proteins 
include the telomere repeat factors 1 and 2 (TRF1 and TRF2; 
bind double-stranded telomeric DNA) and protection of tel-
omeres 1 (POT1; binds single-stranded telomeric DNA) (3–5). 
These end-binding proteins are thought to facilitate invasion 
of the 3′ single-stranded overhang into the telomeric DNA 
duplex, forming a lariat-like structure termed a T-loop (6). 
The T-loop is proposed as an architectural answer to the “end-
capping problem,” in that it not only helps protect the end of 
the chromosome from nucleolytic degradation but also serves to 
prevent this naturally occurring DNA double-stranded end from 
being recognized as broken DNA (i.e., a double-strand break; 
DSB) and initiating inappropriate damage responses (e.g., non-
homologous end joining; NHEJ). Due to the semiconservative 
nature of DNA replication and the requirement for an RNA 
primer in lagging-strand synthesis, conventional polymerases 
are unable to replicate to the very end of the chromosome. This 
so-called “end replication problem” (7, 8) results in progressive 
erosion of the telomere with each round of cellular division 
(~30–150 bp per cell division) and is the molecular mechanism 
underlying the finite replicative lifespan of human somatic cells 
known as the Hayflick limit (9). Once some stipulated number of 
telomeres reaches a critically shortened length, a persistent DNA 
damage response (DDR) is triggered that results in a state of 
permanent cell cycle arrest known as replicative senescence (10). 
Direct links between telomere dysfunction – in terms of either 
significant shortening or compromise of end-capping structure/
function – instability and cancer, as well as senescence- and age-
related degenerative pathologies (e.g., cardiovascular disease) 
have been demonstrated (11–13).
Clearly, during carcinogenesis, cells must devise a means 
of maintaining their telomeres in order to overcome the bar-
rier of senescence and achieve replicative immortality. The 
overwhelming majority of human cancers (~90%) accom-
plish this task by the way of reactivation of telomerase (14); 
the remaining ~10% of cancers maintain telomere length in 
a telomerase-independent fashion, relying instead on the 
homologous recombination (HR)-associated alternative 
lengthening of telomeres (ALT) pathway (15). Telomerase is 
a specialized reverse transcriptase consisting of a catalytic 
subunit, telomerase reverse transcriptase (hTERT), which 
utilizes its telomerase RNA component (hTERC) to synthe-
size telomeric DNA de novo (16, 17). In humans, telomerase 
activity is transcriptionally repressed in the majority of 
somatic cells, being expressed at appreciable levels only in 
adult stem- and germ-line cells (18). It is becoming increas-
ingly appreciated that telomere maintenance and telomerase 
activity are critical elements of intricate cellular networks 
that regulate cellular lifespan, genome stability, and carcino-
genesis. Indeed, recent studies suggest that telomerase has 
novel molecular functions well beyond its canonical role 
in telomere length maintenance, including transcriptional 
regulation and cellular reprograming, which may well under-
lie all of the hallmarks of cancer (19).
Adult stem cells (SCs), rare subpopulations within tis-
sues that possess extended replicative lifespans by virtue of 
possessing telomerase activity, are defined by the distinctive 
properties of self-renewal and the potential to differentiate 
along various lineages. Deregulation of SC compartments is 
generally deemed a contributing factor in the development of 
cancer stem cells (CSCs), which are also referred to as tumor-
initiating cells (20). For example, a subpopulation of CSCs 
(CD44+/CD24low/−) has been identified in human breast tumors 
and established breast cancer cell lines that display enhanced 
tumor-forming capacity in mouse xenograft models (21). Also 
relevant in this regard, are reports that ionizing radiation (IR) 
alters the cellular dynamics of tissue and tumor repopulation 
following exposure and further, that such alteration may be 
dependent on radiation quality, i.e., linear energy transfer 
(LET). LET describes the amount of energy an ionizing particle 
transfers to the material traversed per unit distance and is the 
predominant factor underlying differences in relative biological 
effectiveness (RBE) of charged particle vs. photon radiations. 
For example, high dose per fraction low LET X-ray exposures 
have been associated with subsequent enrichment of putative 
CSC populations in a variety of tumor types including breast, 
colon, lung, prostate, squamous cell carcinoma of the head 
and neck, and melanoma (22–32). Tang et  al. demonstrated 
that low dose γ-ray and charged particle exposures (Fe and 
Si ions) in combination with transforming growth factor beta 
(TGF-β) resulted in increased self-renewal of CK14+/CK18+SC 
populations in the humanized mammary fat pads of juvenile 
mice (33). Such IR-induced SC enrichment has been implicated 
in radiotherapy failure, accelerated repopulation, and evasion 
of tumors to CSC targeted therapies (34). Studies increasingly 
support SCs as critical considerations in the radiation response, 
whether associated with treatment of cancer (radiotherapy) or 
exposure of normal tissues (carcinogenesis) as occurs unavoid-
ably in conjunction with radiotherapy and a variety of medical 
diagnostic procedures, as well as accidentally (e.g., nuclear 
power plant accidents) and during spaceflight.
It is widely viewed that IR-induced enrichment of CSCs 
results from mobilization and asymmetric division of existing 
CSCs, which have been shown to be more radioresistant than 
their more differentiated non-stem cancer cell (NSCC) counter-
parts, due not only to their residing in relatively hypoxic niches 
but also because they possess enhanced DNA repair kinetics, 
superior endogenous oxidative stress defenses, and slower cell 
turnover rates (35). Importantly, however, Lagadec et al. have 
shown that IR-induced enrichment of CD44+/CD24low/− and 
aldehyde dehydrogenase (ALDH) activity high breast CSCs 
can also result from the reprograming or conversion of NSCCs 
back into CSCs by inducing expression of transcriptional fac-
tors utilized in the generation of induced pluripotent stem cells 
(iPSCs), e.g., Oct4, Sox2, and Nanog (29). Additional evidence 
of such “plasticity” was provided by Yang et al., who not only 
November 2015 | Volume 5 | Article 2573
Sishc et al. Telomeres and Telomerase in the Radiation Response
Frontiers in Oncology | www.frontiersin.org
confirmed IR-induced reprograming but also demonstrated 
that CSC populations maintain an equilibrium within estab-
lished cell lines, and that the return to equilibrium is facilitated 
by radiation exposure and TGF-β (23). Therefore, enrichment 
of CSC populations following radiation exposure may arise 
either by way of mobilization (i.e., asymmetric division) of 
existing, radioresistant SC populations in response to injury, 
or via IR-induced reprograming (i.e., conversion) of NSCCs 
into CSCs, or perhaps more likely, some combination of the 
two processes. Implicit in these observations, is the reality that 
therapeutic strategies seeking to target CSC populations must 
address both mobilization and reprograming in order to be 
effective.
Interestingly, the reverse transcriptase component of telomer-
ase (hTERT) has also been implicated as a promoter of “stemness” 
via interactions with the Wnt/β-catenin signaling and NF-κB 
inflammation response pathways (36–40), although such find-
ings remain controversial (41, 42). Telomerase activity has also 
been shown to be radiation-inducible in a variety of tumors and 
cancer cell lines, including mammary carcinoma, acute myeloid 
leukemia (AML), colon carcinoma, squamous cell carcinoma 
of the oral cavity, lymphoma, and nasopharyngeal carcinoma 
(28, 43–50). Such observations led us to suspect unappreciated 
correlations between these processes. Furthermore, exposures 
to high LET, high charge, high energy (HZE) particles, such as 
those delivered during carbon ion radiotherapy or encountered 
in the deep space environment, have been shown to invoke very 
different biological responses than low LET radiations, which 
may well include IR-induced telomerase activity and subse-
quent SC enrichment. The effects of IR exposure, particularly 
radiations of different qualities, on telomere maintenance and/
or function are poorly understood [reviewed in Ref. (51)], even 
though telomeres themselves have been regarded as “hallmarks 
of radiosensitivity” (52), and recently proposed as informative 
biomarkers of radiosenstivity for the purposes of personalized 
medicine (53). Indeed, short telomeres have been shown to 
enhance IR sensitivity in several settings (54–57), being associ-
ated with impaired and/or delayed DSB repair kinetics (54, 58), 
as well as with persistent chromosomal breaks and cytogenetic 
profiles characterized by complex aberrations and massive 
fragmentation (54). However, it is important to note that longer 
telomeres do not necessarily confer radioresistance. It is also 
debatable whether such a relationship holds true in telomerase 
positive cells, as there are reports of no correlation between 
telomere length and radiosensitivity (59). Other contrasting 
reports include longer telomeres in irradiated (4 Gy X-rays) vs. 
unirradiated cells 14 days after exposure (45), as well as signifi-
cantly shortened telomeres, specifically in the shortest telomere 
fraction, in the peripheral blood of radiotherapy patients within 
a relatively short span of time (3 months or less) following treat-
ment for a variety of cancer types (60). Interestingly, low LET 
X-rays and low energy (high LET) protons have been shown 
to induce very different telomeric responses, in that telomeres 
were shortened 96  h post-X-ray exposure and associated with 
anaphase bridges and dicentrics, while high LET protons evoked 
telomere lengthening at 24 and 96 h (56).
Considerable controversy and uncertainty surround such 
results and the processes responsible for them, but accumulat-
ing evidence, including much of our own [e.g., Ref. (61–67)], 
continue to support intimate relationships between function-
ally intact telomeres and the genomic, cellular, and organismal 
responses to radiation exposure. Here, we provide new insight 
into the roles of telomeres and telomerase in the radiation 
response. Specifically, we investigated the influence of dose, 
dose rate, and radiation quality on IR-induced changes in 
telomere function, length, and telomerase activity in panels of 
cancer and non-cancer mammary epithelial and hematopoietic 
cells. Depletion of the telomeric end-binding proteins TRF1, 
TRF2, or POT1 resulted in dysfunctional telomeres that 
were uncapped as opposed to critically shortened, which (1) 
increased spontaneous and IR-induced mutation frequencies 
in a radiation quality-dependent manner, with POT1 depletion 
being especially effective, and (2) contributed to instability in 
that they were susceptible to fusion with each other and to 
IR-induced DSBs, as well as to recombination (telomere sister 
chromatid exchange; T-SCE). Furthermore, we demonstrate 
that IR-induced SC enrichment is telomerase dependent, and 
separate modeling efforts support the necessity of contribution 
from cellular reprograming for such enrichment (manuscript in 
preparation, Gao et al.). Better understanding of these funda-
mental processes involving telomeres and telomerase following 
IR exposure, particularly of different radiation qualities, is 
vital, as they play potentially critical roles in accelerated tumor 
repopulation following radiotherapy, as well as IR-induced 
carcinogenesis following exposure, including those of relevance 
to astronauts.
MaTerials anD MeThODs
cell culture
The spontaneously immortalized non-tumorigenic human 
mammary epithelial cell line MCF-10A was purchased from 
ATCC and was cultured as described previously (68) in 1:1 
Dulbecco’s modified essential medium (D-MEM)/Ham’s F12 
growth medium (Hyclone) supplemented with 5% fetal bovine 
serum (FBS), 10  μg/mL insulin (Sigma), 20  ng/mL epidermal 
growth factor (EGF; Sigma), 0.5 μg/mL hydrocortisone (Sigma), 
0.1  μg/mL cholera toxin (Sigma), and 1% GlutaMAX (Gibco, 
Life Technologies). The human mammary carcinoma cell line 
MCF-7 (kind gift from L. Chubb, CSU Flint Animal Cancer 
Center) was grown in D-MEM supplemented with 10% FBS and 
1% GlutaMAX. The primary normal mammary epithelial cell line 
AG11137 (Coriell) was grown in MCDB 170 complete growth 
medium (US biological) supplemented with 5  μg/mL insulin, 
10  ng/mL EGF, 0.5  μg/mL hydrocortisone, 56  μg/mL bovine 
pituitary extract (Life Technologies), and 1% GlutaMAX.
A human low passage lymphoblastoid cell line (LCL15044, 
kind gift from A. Sigurdsson, National Institute of Health) was 
grown in RPMI medium supplemented with 15% FBS and 1% 
GlutaMAX. The WTK1 human lymphoblastoid cell line was 
derived from the WI-L2 line (69), and used for mutation analysis, 
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as they are heterozygous at the thymidine kinase (TK) locus; 
they also have a single amino acid substitution in codon 237 at 
TP53. WTK1 cells were grown in RPMI medium supplemented 
with 10% horse serum and 1% GlutaMAX. The human, therapy-
induced AML cell line KG1a (kind gift from Michelle LeBeau, 
University of Chicago) was grown in RPMI media supplemented 
20% FBS and 1% GlutaMAX. Normal human peripheral blood 
mononuclear cells (PBMCs) were collected in accordance with 
approved IRB protocol [#13-4379H] in 10  mL spray-coated 
K2EDTA tubes and cultured in PB-MAX karyotyping medium 
containing the activating mitogen, phytohemagglutinin M 
(PHA-M) and supplemented with 1% antibiotic/antimycotic 
(Gibco, Life Technologies).
A variety of control cell lines were included for compari-
son. Primary BJ-1 normal human foreskin fibroblasts (kind 
gift from J. Shay, University of Texas Southwestern Medical 
Center) and hTERT-immortalized BJ-1 (BJ-1-hTERT; 
kind gift from J. Bedford, Colorado State University) were 
grown in a 4:1 mixture of D-MEM high glucose medium 
(Hyclone)/M-199 (Hyclone) supplemented with 10% FBS 
and 1% GlutaMAX. The human osteosarcoma ALT cell lines 
U2OS and SAOS2 (kind gift from D. Gustafson CSU Flint 
Animal Cancer Center) were grown in McCoy’s 5A growth 
medium (Gibco, Life Technologies) supplemented with 10% 
FBS and 1% GlutaMAX. The highly telomerase-positive 
human immortal HeLa cell line was purchased from ATCC 
and cultured in D-MEM high glucose medium, supplemented 
with 10% FBS and 1% GlutaMAX. All cells were maintained 
in a humidified incubator at 37°C in 5% CO2 and passaged 
1–2 times/week.
irradiations and clonogenic cell survival
For γ-Ray Exposures
For γ-ray exposures, cells were exposed to various, acute doses 
of 137Cs γ-rays in a Mark I irradiator (J. L. Shepherd) located at 
Colorado State University. Cells were exposed at a dose rate of 
2.5 Gy/min with rotation. For LDR exposures, cells were incu-
bated under a 137Cs source to total doses of 1 or 4 Gy γ-rays at dose 
rates of 4.9 and 3.12 cGy/h. Unirradiated controls were kept in a 
separate incubator under identical conditions.
Exposures to 1 GeV/n 56Fe Ions
Exposures to 1 GeV/n 56Fe ions (HZE) were delivered at the NASA 
Space Radiation Laboratory (NSRL), located at Brookhaven 
National Laboratory (BNL), Upton, NY, USA. Flasks of cells were 
shipped from Colorado State University in insulated containers at 
room temperature and were exposed to acute doses of 1 or 2 Gy at 
a dose rate of ~1 Gy/min. Immediately following exposure, cells 
were shipped overnight back to Colorado State University for 
processing and analysis.
Clonogenic Cell Survival
MCF-7 and MCF-10A cells were seeded in triplicate 48 h prior 
to irradiation and allowed to incubate under standard culture 
conditions to ensure that all cultures were in log phase. Cells 
were irradiated with an acute dose of 1–10 Gy of 137Cs γ-rays. 
Cells were then allowed to incubate for 16 h overnight to allow 
for repair to occur. Cells were then trypsinized, counted, and 
plated at the appropriate density in quadruplicate into 60 mm 
culture dishes. Cells were allowed to incubate for 10 (MCF-7) or 
14 days (MCF-10A). Plates were then fixed in absolute ethanol, 
stained in crystal violet, and colonies with >50 cells counted. 
This process was repeated three times to generate the data pre-
sented here.
Telomeric sirna Knockdowns
As per our previous reports (62–64, 68), small interfering 
RNA (siRNA)-mediated knockdown of the telomere-binding 
proteins TRF1, TRF2, and POT1 was performed in the 
WTK1 lymphoblastoid cell line prior to shipment to BNL 
for irradiation. Cells were cotransfected (RNAiMAX; Life 
Technologies) with a pool of four individual siRNAs directed 
against each target protein. Specific siRNA sequences are 
as follows: for TRF1: 5′CAAAUUCUCAUAUGCCUUU3′, 
CAGUAGUAGUCCUUUGAUA, AGAGUAACCUAUAAG 
CAUG, and UACCAGAGUUAAAGCAUAU; TRF2: 
GAACAAGCGCAUGACAAUA, GCAAGGCAGCUACGG 
AAUC, GACAGUACAACCAAUAUAA, and CCGA 
ACAGCUGUGAUGAUU; and POT1: GUAGA 
AGCCUUACGUGUUU, GAUAAAACAUCGUGGAU 
UC, GCAUAUCCGUGGUUGGAAU, and UAACUUGC 
CUGCUCUUUAG. Reduced protein levels were verified via 
Western blot 72 h post-transfection using monoclonal antibod-
ies for TRF1 (Novus Biologicals 57-6), TRF2 (Novus Biologicals 
NB110-57130SS), and POT1 (Novus Biologicals NB500-176).
Depletion of hTERT and hTERC levels in MCF-7 and MCF-
10A cells was achieved using prevalidated Silencer Select siRNAs 
purchased from Ambion (Life Technologies, hTERT: 4392420 
and hTERC: 4390771). Non-target control (NTC) siRNA (Life 
Technologies, AM4611) was utilized as a negative control. The 
effectiveness of hTERT and hTERC depletion in reducing telom-
erase activity was verified using RT-qPCR TRAP.
cytogenetic analyses
Chromosome-Orientation Fluorescence In situ 
Hybridization
Chromosome-orientation fluorescence in  situ hybridization 
(CO-FISH) was employed to evaluate IR-induced chromosomal 
instability and performed as previously described (62, 70) with 
some modification. Following irradiation, cell cultures were 
incubated for various times, trypsinized, and subcultured into 
medium containing 5-bromo-2-deoxyuridine (BrdU, 10  μM; 
Sigma-Aldrich) for one cell cycle. Slides were stained with Hoechst 
33258 (0.50  ng/μL; Sigma-Aldrich) for 15  min and exposed 
to 365  nm UV light (Stratalinker 2400) for 25  min. Following 
UV exposure, BrdU incorporated strands were digested with 
Exonuclease III (3 U/μL in provided reaction buffer; Promega) 
at room temperature for 10  min. Slides were hybridized with 
a Cy-3 conjugated (TTAGGG)3 PNA telomere probe (0.2  μg/
mL; Applied Biosystems) at 37°C for 1.5  h, rinsed in 70% for-
mamide at 32°C for 10 min, and dehydrated in another ethanol 
series before re-probing at 37°C for 2  h. Following the second 
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hybridization, slides were rinsed with 70% formamide at 32°C 
for 15 min followed by 5 min rinse in PN buffer. Chromosomes 
were counterstained with DAPI (4,6-diamidine-2-phenylindole 
dihydrochloride; Vectashield, Vector Laboratories). Preparations 
were examined and images captured and analyzed using a Zeiss 
Axioskop2 Plus microscope equipped with a Photometrics 
Coolsnap ES2 camera and running Metavue 7.1 software.
Scoring Criteria
Telomere sister chromatid exchange was scored as a CO-FISH 
telomere signal split between the two chromatids of a metaphase 
chromosome, which were often of unequal intensity due to 
unequal SCE (71). Telomere fusion necessitates that telomeres 
of adjoining chromosomes/chromatids fuse into a single 
CO-FISH signal and the DAPI signal remain continuous (61). 
Telomere–DSB (T-DSB) fusion appears as single-sided (i.e., on 
only one chromatid of a mitotic chromosome) interstitial blocks 
of CO-FISH telomere signal (66, 67). Statistical analyses by Chi-
square or Fisher’s exact test (Sigma Stat 3.5; Systat Software) was 
done to determine significance.
Mutation Frequency analysis
Mutation Assay
WTK1 lymphoblasts were treated with CHAT (10–5M 2′-deoxy-
cytidine, 2 × 10−4M hypoxanthine, 2 × 10−7M aminopterin, and 
1.75 ×  10−5M thymidine; Sigma) for 2  days and CHT (CHAT 
without aminopterin) for 1  day to eliminate pre-existing TK− 
mutants. Following CHAT treatment, cells were transfected with 
TRF1, TRF2, or POT1 siRNA and/or treated with the DNA-PKcs 
inhibitor Nu7026 (Sigma-Aldrich). Three days later, cells were 
irradiated with γ-rays or HZE particles. Two days after irradia-
tion, when phenotypic expression of newly induced mutants was 
complete, the mutant fractions (MFs) were determined. For 
plating efficiency, 1 cell/well was seeded, or for scoring mutants, 
2000 cells/well were seeded in the presence of 2 μg/mL trifluoro-
thymidine (TFT; Sigma-Aldrich). Fresh TFT was added 11 days 
after plating, and plates were scored for positive or negative wells 
after 20 days. The MFs were calculated using the Poisson distribu-
tion, and statistical analyses were done by t-tests using Sigma Stat 
3.5 (Systat Software).
Telomere length analysis
Interphase Telomere Fluorescence In situ 
Hybridization
Samples were prepared using standard cytogenetic techniques as 
described previously with slight modifications (68, 72, 73). Briefly, 
cultured cell pellets were resuspended in 8 mL of 75 mM potas-
sium chloride (KCl; hypotonic) and incubated for 30 min at 37°C. 
Following incubation, 1 mL of fixative (3:1 methanol acetic acid) 
was added, cells were pelleted at 1000 rpm for 5 min, resuspended 
in 6 mL fixative, and stored at −20°C. Fixed cell pellets were then 
washed and dropped onto glass slides for telomere fluorescence 
in situ hybridization (FISH), which was performed as described 
previously with modifications (74). Briefly, slides were treated 
with 100 μg/mL RNASE A in 150  mM NaCl, 15  mM sodium 
citrate buffer for 30 min at 37°C, dehydrated through an ethanol 
series (75, 85, and 100%), and denatured in a 70% formamide/2× 
saline sodium citrate (SSC) solution at 70°C for 2 min. A telomere 
peptide nucleic acid (PNA) probe (TTAGGG)3 labeled with Cy-3 
was hybridized onto the slides at 37°C overnight. Slides were 
washed twice each in 50% formamide/2× SSC, 2× SSC, and 0.1% 
NP-40 in 2× SSC for 2.5 min each at 43°C. Finally, slides were 
mounted in Prolong Gold Antifade reagent (Invitrogen) contain-
ing 4′,6-diamidino-2-phenylindole, dihydrochloride (DAPI).
Image Z stacks were taken using a Zeiss Axio Imager.Z2 
microscope, with a Coolsnap ES2 camera running Metamorph 
7.7 (Molecular Devices). For each slide, 30–50 images were 
obtained, each consisting of 22, 0.2  μm stacks. Metamorph 
nearest neighbor deconvolution and stack compression func-
tions were applied, followed by image thresholding (upper and 
lower threshold values were held consistent across experiment). 
Finally, a region of interest was created for each nucleus, and 
the intensities of individual telomeres obtained in metamorph. 
Fluorescence values in each batch of FISH were standardized 
to the fluorescence intensity of an LY-R mouse lymphoma cell 
pellet as an internal control. LY-R cells have long brightly staining 
telomeres and their use for standardization, which was adapted 
from Q-FISH (75), represents a means to accurately compare 
relative telomere lengths from run to run.
Senescence-Associated β-Galactosidase Assay
Irradiated and control cells were rinsed twice with PBS, fixed for 
15  min in 4% paraformaldehyde at room temperature, rinsed 
with PBS and covered with freshly prepared β-galactosidase 
staining solution (Cell Signaling Cat #9806). Cells were incubated 
at 37°C in a dry incubator for 18 h, staining solution was aspirated 
and replaced with 70% glycerol, then imaged immediately on an 
EVOS digital microscope. Images were taken of each sample 
under phase contrast at 40×. Blinded subjective scoring of blue 
cells was used to quantify senescent cell fractions.
Telomerase analysis
Telomerase Activity
Telomerase activity was evaluated using the telomere repeat 
amplification protocol (TRAP) assay originally described by 
Herbert et  al. (76) and adapted for quantitative real-time PCR 
by Hou et al. (77). Briefly, whole cell lysates were prepared from 
cultured cell pellets and lysed in cold MPER mammalian protein 
extraction buffer (Thermo Fisher) containing a protease inhibitor 
cocktail (Roche) and RNasin ribonuclease inhibitor (Promega) 
at a ratio of 100 μL of buffer per 1,000,000 cells. Lysates were 
cleared by centrifugation at 14,000 rpm for 10 min at 4°C and 
stored at −80°C. Protein concentration was determined using the 
Bradford Assay (Biorad).
The SYBR green master mix (Promega) included all compo-
nents for the RTQ-PCR. Each well contained between 0.1 and 
0.25 μg protein lysate, 50% volume SYBR green master mix, 0.2 μg 
T4 gene32 protein (New England Biolabs, Ipswitch, MA, USA), 
0.1 μg of each primer TS (5′-AATCCGTCGAGCAGAGTT-3′) 
and ACX (5′-GCGCGG(CTTACC)3CTAACC-3′) (Integrated 
DNA Technologies), and RNase/DNase-free water to achieve 
a final well volume of 25  μL. The PCR and detection were 
performed on a CFX 96 (Biorad). In addition to the treatment 
samples, a series of controls were included on each plate: (1) no 
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template control with TS primer only, (2) no template control 
with ACX primer only, (3) no template control with TS and ACX 
primers (used in normalization of samples), (4) heat inactivated 
control with template (protein lysate) and TS and ACX primers, 
and (5) HeLa cell lysate with TS and ACX primers (a positive 
control).
The RTQ-PCR program included the following steps: step 1, 
one cycle 25°C 20 min (telomerase elongates the TS primer by 
adding TTAGGG repeat sequences); step 2, one cycle 95°C 3 min 
(heat activation of the enzyme in the SYBR master mix); step 3, 
40 cycles of 95°C 20  s, 50°C 30  s, and 72°C 1  min 30  s (PCR 
amplification allows for detection by real-time instrument); and 
step 4, 80 cycles 0.10 s per cycle (melt curve to ensure no primer 
dimer formation). Each sample was run in triplicate on a 96-well 
plate format allowing for an average Ct to be obtained per sample. 
Utilizing the average Ct value, the relative percent telomerase 
activity in each sample is calculated using the Delta Delta Ct 
method (2−ΔΔCt) (78). Briefly, to calculate the percent relative 
activity for each sample, first normalize the average sample Ct to 
the no template control with TS and ACX primers. This is referred 
to as the delta Ct value. The delta Ct value of each sample is sub-
tracted from the delta Ct value of a chosen comparative sample, 
in this case a normal feline mucous membrane cell lysate, yielding 
a delta delta Ct value (ΔΔCt). Using the 2−ΔΔCt, a relative value 
is generated for each sample comparison and when multiplied 
by 100 is the relative percent of telomerase activity (RTA) of 
the sample compared to the control. The RTA can be compared 
between samples assayed across different plates. Results from two 
runs were averaged.
Telomerase Expression
Telomerase expression (hTERT and hTERC) was evaluated by 
quantitative reverse transcription PCR (qRT-PCR). Total RNA 
was harvested from irradiated and unirradiated samples using 
the Qiagen RNeasy kit (Qiagen). RNA was quantified using a 
Nanodrop 1000 spectrophotometer and reverse transcribed 
using the Verso cDNA kit (Thermo Scientific). Real-time PCR 
was performed using SYBR green master mix (Promega) accord-
ing to the manufactures protocol and performed using a CFX 
96 system (Biorad). The real-time cycle was as follows: cycle 1 at 
95°C 15 min, cycle 2 (50×) step 1 at 95°C 15 s, step 2 at 58°C 30 s, 
and step 3 at 72°C 30 s. A melt curve was included to assess primer 
dimers and non-specific amplification as follows: cycle 3 at 95°C 
30 s, cycle 4 at 55°C 30 s, and cycle 5 (80×) at 55°C 10 s. Primers 
were designed using the Primer3 program (79) using a published 
cDNA library for hTERT (80) and hTERC (80). hTERT primers 
were added (final concentration 300  nM) including a forward 
sequence: 5′CCATCAGAGCCAGCTTCACCT3′ and reverse 
sequence: 5′TCACCTGCAAATCCAGAAACA3′. hTERC 
primers were added (final concentration 300  nM) including a 
forward sequence: 5′AAGAGTTGGGCTCTGTCAGC3′ and 
reverse sequence: 5′TCCCACAGCTCAGGGAATC3′. Primers 
for transferrin receptor (TFRC) were included (final concentra-
tion 100 nM) as a housekeeping gene with the forward sequence: 
5′CGCTGGTCAGTTCGTGATTA3′ and the reverse sequence: 
5′GCATTCCCGAAATCTGTTGT3′. Relative hTERT and 
hTERC RNA expressions were analyzed using the 2−ΔΔCt method.
Telomerase Activity Inhibition
Telomerase activity inhibition was accomplished using the small 
molecule inhibitor MST-312 (Sigma), also known as telomerase 
inhibitor 1× (81). Briefly, MST-312 was solubilized at concentra-
tions recommended by the manufacturer in sterile DMSO and 
stored at −20°C for no more than 1 month prior to use. Dose 
response for inhibition of telomerase activity was established, 
and MST-312 (1–3  μM) was added to cultures 6  h prior to 
experimentation.
Thiazolyl Blue Tetrazolium Bromide (MTT) Assay
Thiazolyl blue tetrazolium bromide (MTT) assay was used to 
evaluate potential cytotoxic effects of the MST-312 telomerase 
inhibitor as described previously (82). Briefly, 2000  cells/
well of a 96-well plate were seeded 24 h prior to addition of 
inhibitor. Media were removed and replaced with fresh media 
containing varying concentrations of MST-312 or an equiva-
lent DMSO control. Cells were incubated in the presence of 
inhibitor for 48 or 72 h. At the time of analysis, media was once 
again removed from wells, and cells were resuspended in fresh 
media containing 0.5 mg/mL MTT reagent and incubated at 
37°C for 3.5 h. Following incubation, media was removed and 
150 μL MTT solvent (4 mM HCl, 0.1% NP-40, all in isopro-
panol) was added to each well and set to agitate on a shaker 
at room temperature for 15 min. After agitation, plates were 
read on a Modulus Microplate reader (Turner Biosystems) at 
600 nm absorbance.
stem cell analyses
Immunophenotyping
Putative human mammary epithelial CSCs were identified based 
on the expression of CD44+/CD24low/− surface markers (83–85). 
Putative CSCs from human hematopoietic cell lines were identi-
fied based on the expression of CD34+/CD38low/− or CD34+ 
expression alone (86). All analyses were performed on a CyAn 
ADP Analyzer with nine-color capability (Beckman Coulter 
CY20130) located at the Colorado State University Veterinary 
Teaching Hospital. Monolayers MCF-7 and MCF-10A mam-
mary epithelial cells or hematopoietic cells in suspension were 
dissociated and stained for marker expression. Briefly, ~300,000 
cells were dissociated from cell culture surface using 0.25% 
trypsin-EDTA, pelleted, washed, and resuspended in 30 μL flow 
cytometry wash buffer (1× PBS, 1% FBS, and 1% penicillin/
streptomyocin), 6  μL of FITC-conjugated mouse monoclonal 
antihuman CD44 antibody (BD Pharmingen #555478), and 6 μL 
of Pe-conjugated mouse monoclonal antihuman CD24 antibody 
(BD Pharmingen #555428). Cells were incubated for 30–60 min 
in the dark at 4°C, then pelleted and resuspended in 500  μL 
cold 1× PBS and kept on ice until analysis. Analysis gates were 
established using cells from unstained controls and antimouse 
Ig,κ antibody capture beads (BD Pharmingen #552843). For 
lymphoblastoid suspension cultures, cells were stained as above 
with 6 μL of direct PE-conjugated mouse monoclonal antihuman 
CD34 antibody (BD Pharmingen #555822) and 6 μL of direct 
FITC-conjugated mouse monoclonal antihuman CD38 antibody 
(BD Pharmingen #560982).
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Aldefluor Assay
Enhanced ALDH activity, an accepted marker of SCs, was 
detected using the ALDEFLUOR Kit (Stem Cell Technologies) as 
described previously (29). Briefly, ~300,000 MCF-7 or MCF-10A 
cells were trypsinized, resuspended in aldefluor buffer, and incu-
bated with aldefluor reagent (both provided and as recommended 
by manufacturer). Samples from all treatment groups were also 
treated with the ALDH inhibitor DEAB (Stem Cell Technologies) 
and utilized as negative controls to establish gating. Cells were 
pelleted, aspirated, resuspended in buffer containing efflux 
inhibitor, and analyzed on a flow cytometer.
Mammosphere Assay
Evidence of SC character was also evaluated in MCF-7 and MCF-
10A mammosphere cultures and their respective sorted popula-
tions, which were plated in low bind cell culture plates (Nunc) 
using Mammocult Media (Stem Cell Technologies). Cells were 
plated into 96-well plates at limiting dilutions, then allowed to 
form spheres for up to 10 days with fresh media supplementation 
every 3 days. Sphere formation was evaluated on day 10 using an 
inverted bright field microscope, and spheres with a size >100 μM 
in diameter were scored.
resUlTs
Depletion of Telomeric end-capping 
Proteins increases radiation-induced 
Mutation Frequencies and chromosomal 
instability
We have shown that TRF2 fails to colocalize with IR-induced 
DSBs and so is not an “early responder” to such DNA damage 
(87). However, siRNA depletion of any of the directly binding 
end-capping telomere proteins TRF1, TRF2, or POT1 resulted 
in elevated spontaneous and IR-induced mutation frequencies 
(MF) at the heterozygous TK locus in human lymphoblastoid 
cells (WTK1) following both γ-ray and 1 GeV/n 56Fe ion expo-
sures (Figure 1). Overall, IR-induced MFs upon telomere protein 
depletion were similar both quantitatively and qualitatively, 
although POT1 depletion resulted in the highest elevation of MF 
(significant at 2 Gy Fe). No statistically significant differences in 
MF between γ-rays and 1 GeV/n 56Fe ions (HZE) were observed in 
these experiments. However, in this same lymphoblast mutation 
system, an RBE for Fe of ~3 was recently suggested; this resulted 
from utilizing a different, more immediate plating protocol that 
facilitated recovery of more mutants following HZE exposure (88). 
Therefore, we can now surmise that the MFs for Fe in the earlier 
experiments reported here are likely two to threefold higher than 
shown. This in turn would imply important differences for HZE 
exposures in the context of telomere deficiencies. Interestingly, 
telomere deficiencies consistently resulted in higher MF than 
inhibition of DNA-PKcs kinase activity, a well-characterized 
contributor to DNA repair, providing additional support for the 
significance of telomere proteins in the DDR. Furthermore, MF 
in the context of combined TRF2 knockdown and inhibition of 
DNA-PKcs kinase activity was not additive, suggesting that they 
act in the same pathway. These results are consistent with the 
proposition that TRF2 prevents C-NHEJ-mediated end fusion, 
while DNA-PK thwarts alternative-NHEJ at telomeres; thus, tel-
omeres are protected by a “lock with two bolts” (89). Curvilinear 
dose responses for individual knockdowns were also suggested 
(Figure 1), indicating intertrack interaction of multiple lesions 
at higher doses, and likely reflecting additional interactions 
between dysfunctional telomeres and IR-induced DSBs (T-DSB 
fusions) (66); such a supposition is supported by increased 
frequencies of these events at 2 Gy (Figure 2).
The contribution of telomere end-capping function to 
IR-induced chromosomal instability was also evaluated, as per 
our previous works (61–63, 67). T-SCE is a recognized marker 
of unregulated telomeric recombination events (71), whereas 
telomere–DSB (T-DSB) fusion events result from inappropriate 
end joining (66). Quantification of T-SCE and T-DSB fusion fre-
quencies associated with siRNA knockdown of TRF2 or POT1 in 
WTK1 cells, both spontaneously and following acute exposure to 
either 2 Gy γ-rays or 2 Gy 1 GeV/n 56Fe ions is shown (Figure 2). 
Successful siRNA knockdown of TRF1, TRF2, and POT1 in 
WTK1 cells 72 h post-transfection was verified by Western blot 
(Figure S1 in Supplementary Material).
Depletion of either TRF2 or POT1 elevated T-SCE frequen-
cies following both γ-ray and HZE 2 Gy exposure as compared 
to 0 Gy controls. No statistically significant difference between 
γ-rays and HZE was observed with TRF2 deficiency. However, 
HZE was much more effective than γ-rays at inducing T-SCE in 
the context of POT1 deficiency, consistent with the demonstrated 
role of POT1 during replication (90, 91). Depletion of either 
TRF2 or POT1 also elevated T-DSB fusion events following 2 Gy 
γ-ray or HZE exposure (as compared to 0 Gy controls). Again, 
no statistically significant difference between γ-rays and HZE 
was observed with TRF2 deficiency, a finding consistent with 
TRF2’s role in suppressing ATM at telomeres (90). Interestingly, 
with POT1 deficiency, HZE was less effective at inducing T-DSB 
than γ-rays, supportive of these events not being replication 
dependent, but rather NHEJ mediated, as previously shown (67). 
Together, these results convincingly demonstrate that telomeric 
proteins influence the DDR/repair following IR exposure.
ionizing radiation exposure increases 
Telomerase activity
Previous reports have demonstrated elevated telomerase activity 
following IR exposure; however, results are often conflicting in 
regard to dose, dose rate, radiation quality, method of telomerase 
activity measurement, and cell line examined. Therefore, we sought 
to more clearly characterize telomerase activity in response to a 
variety of IR exposures in both tumor and non-tumor cells. We 
selected panels of human mammary epithelial and hematopoietic 
cell lines representing a wide range of inherent/background 
levels of telomerase activity (high/low/very low) that included 
cancer (MCF-7 and KG1a), non-tumorigenic immortalized 
[spontaneously (MCF-10A) or via EBV (WTK1)], and normal 
primary mammary (AG11137) and low passage lymphoblastoid 
(LCL15044) cell lines. Telomerase activity was evaluated relative 
to the telomerase-positive HeLa cell line (Figure 3). The ALT cell 
lines U2OS and SAOS2 (telomerase-independent maintenance of 
FigUre 2 | compromise of telomeric end-capping function increases radiation-induced T-sce and telomere–DsB fusion events. T-SCE and 
telomere–DSB fusion frequencies in WTK1 lymphoblastoid cells exposed to 0 Gy, 2 Gy γ-rays, or 2 Gy 1 GeV/n 56Fe ions following siRNA knockdown of telomere-
binding proteins POT1 or TRF2.
November 2015 | Volume 5 | Article 2578
Sishc et al. Telomeres and Telomerase in the Radiation Response
Frontiers in Oncology | www.frontiersin.org
telomeres) and BJ-1 primary foreskin fibroblasts (very low tel-
omerase activity) were utilized as negative controls, and hTERT 
immortalized BJ-1 fibroblasts (BJ-1-hTERT) were also used as an 
internal control.
Acute exposure to γ-rays (10 Gy) prompted significantly ele-
vated levels of telomerase activity within 24–48 h in the mammary 
MCF-7 cells (high inherent telomerase activity, 24 h; p = 0.0140, 
48 h; p = 0.0011); a slight, but non-significant (p = 0.2473) elevation 
of telomerase activity was also observed in MCF-10A cells (lower 
inherent telomerase activity) at 48  h (Figure  4A). In contrast, 
a significant reduction of telomerase activity (p =  0.0001) was 
observed 48 h postexposure in the AG11137 primary mammary 
epithelial cells (very low inherent telomerase activity). Evaluation 
of telomerase RNA expression in MCF-7 and MCF-10A follow-
ing acute 10  Gy γ-ray exposure, specifically mRNA levels of 
the catalytic subunit hTERT and expression levels of the RNA 
template hTERC, revealed that hTERT expression in MCF-7 cells 
was significantly increased in the same timeframe that telomerase 
activity was elevated (24–48 h, 24 h; p = 0.0001, 48 h; p = 0.0001); 
hTERC levels in MCF-7 remained significantly elevated for up to 
5 days (24 h; p = 0.0001, 120 h; p = 0.0011). In MCF-10A, hTERT 
expression was significantly decreased 72–120  h postexposure 
(72 h; p = 0.0326, 120 h; p = 0.0337), and hTERC expression in 
MCF-10A was significantly decreased 72–120 h (72 h; p = 0.0005, 
120 h; p = 0.0001; Figure 4D).
The highly telomerase-positive KG1a cell line displayed 
significantly increased levels of telomerase activity 24–48  h 
postexposure (1  Gy, 24  h; p =  0.0024, 48  h; p =  0.0001, 4  Gy, 
24 h; p = 0.0019, 48 h; p = 0.0001; Figure 4B), which was dose 
dependent (1 and 4 Gy γ-rays). A significantly elevated level of 
FigUre 1 | compromise of telomeric end-capping function elevates spontaneous and radiation-induced mutagenesis. TK− mutation frequency (MF) in 
WTK1 lymphoblastoid cells exposed to 0, 1, or 2 Gy γ-rays or 56Fe ions at 1 GeV/n following siRNA knockdown of telomere-binding proteins POT1, TRF1, and 
TRF2, and/or inhibition of DNA-PKcs kinase activity.
FigUre 3 | Telomerase activity in cancer and non-cancer cell lines. 
Relative telomerase activity as determined using the qRT-PCR-based TRAP 
assay and arranged in order from least to greatest background level; normal 
human PBMCs are also included. Consistent with expectation, a natural 
break occurs between those with very low/low activity (LCL15044 and to the 
left; normal, ALT, and often considered negative) and those with higher levels 
of telomerase (MCF-10A and to the right; immortalized, transformed, and 
cancer). Data are represented on a log scale, and all values are reported as 
telomerase activity relative to HeLa cells.
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telomerase activity was also observed in the WTK1 cell line (high 
inherent telomerase activity) at 24 h postexposure (p = 0.0143), 
but only at 4 Gy. The low passage transformed normal lympho-
blastoid cell line LCL15044 (very low telomerase activity) showed 
elevated telomerase activity at 24  h post 1 and 4  Gy exposure, 
but neither rose to the level of significance. Interestingly, normal 
PBMCs (very low telomerase activity) showed elevated activ-
ity 48 h post 1 Gy acute γ-ray exposure, which was significant 
(p = 0.0394; Figure 4C).
Next, we sought to determine if telomerase activity was elevated 
in response to chronic low dose rate (LDR) γ-ray exposure. MCF-
7, MCF-10A, KG1a, and WTK1 cells (relatively high telomerase 
activity) were incubated under chronic LDR conditions to total 
doses of 1 or 4 Gy, delivered at dose rates of 0, 1.17, 3.12, and 
4.98 cGy/h. Telomerase activity was not significantly elevated at 
either 1 or 4 Gy total dose, at any dose rate, in any cell line exam-
ined (Figure 5A). These results imply that in contrast to acute 
exposures, elevation of telomerase activity is not triggered by low 
LET, LDR exposures. However, normal human PBMCs exposed 
to chronic LDR radiation did respond with elevated levels of 
telomerase activity relative to unirradiated controls (Figure 5B).
Telomere length is shortened Despite 
elevated Telomerase activity 
Postexposure
To evaluate the effect of elevated telomerase activity post-IR 
exposure, we assessed telomere length in dividing MCF-7 
and MCF-10A cell populations at 5 and 10  days after a single 
acute dose (10  Gy γ-rays). Unexpectedly, telomere length was 
significantly shortened at the population level 5 days postexpo-
sure in both MCF-7 (p =  0.0001) and MCF-10A (p =  0.0003) 
(as compared to 0 Gy controls), despite the observed elevation 
of telomerase activity 24–48 h after exposure (Figure 6A). There 
was no change in telomere length immediately following a 10 Gy 
dose of γ-rays, ruling out the possibility of IR-induced changes 
in telomere/probe-binding affinity (not shown). Furthermore, 
histogram analysis of individual telomere lengths demonstrated 
that IR exposure shortened all of the telomeres in the population 
(i.e., shifted the entire distribution; Figure 6B), suggesting that 
IR does not “target” the shortest telomeres, those presumed to be 
more radiation sensitive. The observed post-IR telomere short-
ening also corresponded with a significant increase in senescent 
cells (SA-Beta gal positive) at day 5, which remained significantly 
elevated until at least day 10 (Figure 6C). This finding is consist-
ent with well-documented IR-induced senescence; our results 
suggest an underlying contribution of telomere shortening and/
or the inability of telomeres to repair themselves postexposure 
(92–94). Furthermore, by day 10 postexposure, telomere length 
in the surviving cell population began to recover, despite reduced 
levels of telomerase activity during this same time period. These 
results support the notion that following IR exposure, telomerase 
is acting outside of its canonical role in elongating telomeres. 
Telomere length was also decreased in PBMCs following an acute 
exposure (1 Gy) of γ-rays at both 2 and 5 days (2 days; p = 0.0328, 
5 days; p = 0.0362; Figure 6D). Interestingly, a similar decrease 
in telomere length was observed following a 1 Gy LDR exposure 
at 5 (p = 0.0250) (but not 2) days (Figure 6E).
elevation of Telomerase activity Precedes 
ir-induced enrichment of Putative stem 
cell Populations
As normal SC and CSC populations generally possess higher 
telomerase activity than their non-stem counterparts, and 
IR-induced enrichment of putative SC populations in mam-
mary carcinoma cells has been reported by multiple groups (23, 
28, 29, 31, 83), we hypothesized that observations of elevated 
telomerase activity following IR exposure may result from 
the enrichment of CSC populations. Therefore, we examined 
enrichment of putative CD44+/CD24low/− SC populations with 
time in MCF-7 and MCF-10A following an acute 10 Gy γ-ray 
exposure. At the therapeutically relevant dose of 10  Gy, sur-
vival in both cell lines was determined to be <1%, even when 
using a delayed plating method (Figure 7A). However, despite 
this low number of survivors, a significant enrichment in the 
percentage of CD44+/CD24low/− MCF-7 cells began to emerge 
approximately day 2 post exposure (p = 0.0001), peaked at day 
5 (p =  0.0001), and remained elevated at day 7 (p =  0.0001; 
Figure  7B). Interestingly, IR-induced enrichment of CD44+/
CD24low/− cells in MCF-10A cells also occurred at day 5 postex-
posure (p = 0.0001); however, unlike MCF-7 cells, enrichment 
of putative SCs in MCF-10A was very abrupt. Furthermore, 
IR-induced enrichment of mammary CD44+/CD24low/− cells at 
day 5 in MCF-7 displayed a dose response and appeared to have 
a threshold dose of >5  Gy in MCF-10A, meaning that it did 
FigUre 4 | Telomerase activity is elevated at early times following acute γ-ray exposure. Telomerase activity was assessed as a function of time in panels 
of (a) cultured mammary epithelial cell lines, (B) hematopoietic cell lines, and (c) stimulated peripheral blood mononuclear cells (PBMCs) following acute γ-ray 
exposures: 10 Gy (mammary epithelial), 1 and 4 Gy (hematopoietic), and 1 and 5 Gy (PBMCs). In general, cell lines with higher levels of background activity 
experienced higher, more significant elevation of activity 24–48 h postexposure, the notable exception being normal PBMCs (very low telomerase activity; significant 
IR-induced elevation). Telomerase activity in irradiated cells is reported relative to unirradiated control samples collected at the same time point. (D) Time course of 
hTERT mRNA and hTERC levels in MCF-7 and MCF-10A cells following acute 10 Gy exposure.
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not significantly occur at doses lower than 5  Gy (Figure  7C). 
Stem-like character of radiation-enriched SC populations was 
further verified using the aldefluor assay, in which significant 
enrichment of ALDHhigh cells was observed 5  days post acute 
10 Gy γ-ray exposure (MCF-7; p = 0.004, MCF-10A; p = 0.001; 
Figure  7D); mammospheres were also generated from sorted 
populations, providing additional confirmation of stemness in 
the CD44+/CD24low/− populations (not shown). Counter to our 
initial hypothesis, IR-induced elevation of telomerase activ-
ity preceded the observed enrichment of SC compartments, 
indicating that they are not directly correlated (i.e., are not one 
in the same), once again suggesting that telomerase is acting 
in non-canonical ways, likely having to do with SCs, and in 
agreement with previous reports (19, 38). Representative scatter 
plots of MCF-7 and MCF-10A cells immunotyped using CD44+/
CD24low/− antibodies or the aldefluor assay are shown (Figure S2 
in Supplementary Material).
To determine whether the IR-induced enrichment of putative 
SC populations observed in mammary epithelial cells is a more 
general phenomenon that might also occur at lower doses, we 
examined expression of the CD34+/CD38− immunotype in the 
hematopoietic cell line KG1a and the CD34+ immunotype in 
WTK1 and LCL15044 cell lines 1–3 days post 1 or 4 Gy γ-ray 
acute exposure (Figure 8). Interestingly, significant increases in 
CD34+ populations were observed in both WTK1 and LCL15044 
lymphoblastoid cell lines (>99.8% CD34− in unirradiated condi-
tions) following either a 1 or 4 Gy exposure for up to 3 days. In 
contrast, KG1a cells, which possessed a much higher background 
compartment of CD34+/CD38− cells (20–30%), demonstrated 
a dose-dependent decrease in CD34+/CD38− levels with IR 
exposure (Figure 8). This result indicates that radiation does not 
induce enrichment of putative SC populations in all cell lines, 
cancer types, or tissues, which may, at least to some degree, be 
dependent on background levels.
FigUre 5 | Telomerase activity following low dose rate γ-ray exposures. (a) Telomerase activity was assessed in MCF-7, MCF-10A, KG1a, and WTK1 
(relatively high levels of telomerase) chronically exposed to γ-rays at cumulative doses of 1 or 4 Gy at dose rates of 1.7, 3.12, or 4.9 cGy/h. In general, no elevation 
of telomerase activity was observed, with the exception of WTK1 at 1 Gy, 1.7 cGy/h. (B) In contrast, telomerase activity in stimulated PBMCs (very low telomerase 
activity) exposed to a total dose of 1 Gy delivered at low dose rate of 4.9 cGy/h, was significantly elevated (days 2 and 5). Data are expressed as telomerase activity 
relative to unirradiated controls within each group.
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Telomerase activity is required for  
ir-induced enrichment of Putative  
csc Populations
To further investigate the role of telomerase in promoting 
IR-induced enrichment of putative SC populations, we employed 
both a small molecule inhibitor of telomerase activity (MST-312) 
and siRNA depletion of the catalytic subunit (hTERT) of telom-
erase. MCF-7 and MCF-10A cells were treated with MST-312 
at non-cytotoxic concentrations as determined by MTT assay 
(Figure 9A), which resulted in significant and dose-dependent 
decreases in telomerase activity (Figure  9B). Subsequent 
exposure to an acute dose of 10  Gy γ-rays and incubation for 
5  days demonstrated that inhibition of telomerase activity 
effectively blocked IR-induced putative SC enrichment in both 
MCF-7 and MCF-10A (Figure  9C). This finding was further 
substantiated utilizing siRNA directed against hTERT, which 
also significantly reduced the level of telomerase activity in both 
MCF-7 and MCF-10A (Figure  9B). Consistent with results 
using the inhibitor (MST-312), reduction of telomerase activ-
ity via depletion of hTERT also blocked IR-induced putative 
SC enrichment in both MCF-7 and MCF-10A (Figure 9C). As 
expected, siRNA depletion of the RNA subunit, hTERC, did 
not reduce telomerase activity, nor did it block SC enrichment 
FigUre 6 | ionizing radiation-induced telomere shortening in mammary epithelial cells and stimulated PBMcs. (a) Telomere length was significantly 
shortened in MCF-7 and MCF-10A cells at the population level 5 days postacute γ-ray exposure (10 Gy). By 10 days, telomere length had increased but still 
remained significantly shortened compared to unirradiated controls. (B) Histograms of individual telomere lengths in MCF-7 and MCF-10A cells reveal significant 
shortening of all telomeres at days 5 and 10 postexposure. (c) Time course of senescence associated β-galactosidase staining in MCF-7 and MCF-10A cells 
following acute γ-ray exposure (10 Gy). (D) Telomere length was significantly shortened in stimulated PBMCs at 2 and 5 days postacute γ-ray exposure (1 Gy) and 
at 5 days post-LDR γ-ray exposure (1 Gy) delivered at a dose rate of 4.9 cGy/h (24 h). (e) Histograms of individual PBMC telomere lengths following acute and LDR 
exposures (1 Gy) at 2 and 5 days.
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(not shown). Together, these data provide strong evidence in 
support of the necessity of telomerase activity for IR-induced 
enrichment of CD44+/CD24low/− putative mammary CSC 
populations postexposure.
DiscUssiOn
The results reported here provide valuable insight into the criti-
cal roles telomeres and telomerase play in the radiation response 
FigUre 7 | ionizing radiation-induced enrichment of putative mammary stem cell populations. Responses of MCF-7 and MCF-10A mammary epithelial 
cells to acute γ-ray exposure (10 Gy). (a) Clonogenic survival curves and IR dose response. (B) Time course evaluation of putative mammary stem cell 
compartments. (c) Radiation dose response of putative mammary stem cells 5 days postexposure. (D) Quantification of ALDH high cells 5 days postexposure, 
confirming stem cell nature of sorted CD44+/CD24− populations.
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and thereby support further exploration for their roles in the 
context of both radiotherapy and IR-induced carcinogenesis. 
Specifically, we have assessed the roles telomeres play in main-
taining genomic stability following IR exposure, elaborated 
on the role telomerase plays in cell survival and repopulation 
postexposure, and identified a potentially targetable role of 
telomerase activity in cells exposed to therapeutically relevant 
doses of low LET radiation.
Disruption of telomeric end-capping via siRNA depletion 
of end-binding proteins TRF1, TRF2, or POT1 increased 
IR-induced mutation frequencies and chromosomal instability. 
Of relevance in this regard are reports of decreased expression of 
TRF2 associated with increased breast cancer malignancy (95), 
as well as the demonstration of telomere fusions in early human 
breast carcinoma (96). Furthermore, our finding of telomere 
uncapping with POT1 deficiency is consistent with POT1 muta-
tions identified in a subset of patients with chronic lymphocytic 
leukemia (CLL), which were associated with increased levels of 
chromosomal fusions involving telomeres (97). A particularly 
relevant recent report specifically associated various POT1 
variants with telomere length and radiosensitivity in colon and 
gastric adenocarcinoma (98). Our results provide additional sup-
port for the view that in addition to critical telomere shortening, 
telomeres rendered dysfunctional by virtue of deficiencies in 
FigUre 8 | ionizing radiation-induced enrichment of putative hematopoietic stem cell populations. Time course analysis depicting percentages of CD34+ 
(WTK1 and LCL15044) and CD34+/CD38− (KG1a), 1, 2, and 3 days postacute γ-ray exposure (0, 1, or 4 Gy).
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telomeric proteins and the end-capping failure that ensues, also 
contribute to the carcinogenic potential of radiation exposure.
It is also noteworthy that while deficiencies in TRF1 or TRF2 
appeared similar to those associated with NHEJ deficiency in 
regard to telomere instability, which presumably occurred via 
ATM-mediated classic NHEJ (99), the response of cells to IR 
exposure in the setting of POT1 knockdown differed. Not only 
did POT1 depletion result in significantly higher mutation fre-
quencies in response to γ-rays and 56Fe ions (2  Gy; relative to 
TFR1 and TRF2 knockdown) but also a very different pattern of 
chromosomal instability was observed. Specifically, while TRF1 
and TRF2 knockdown resulted in elevated frequencies of both 
T-SCE and T-DSB fusion events in response to both γ-rays and 
56Fe ions, POT1 knockdown displayed a higher level of T-SCE 
(HR mediated) events in response to 56Fe ions relative to γ-rays, 
with the opposite being true for T-DSB (NHEJ mediated) events. 
These observations are consistent with the proposed roles for 
POT1 in suppressing ATR at telomeres (90) and facilitating a 
RPA-to-POT1 switch (91) during replication, and thereby sup-
pressing telomeric recombination, here particularly in response 
to the complex damage induced by high LET radiation exposure. 
Taken together with the reported association of POT1 variants 
with radiosensitivity and colon and gastric adenocarcinoma 
(98), our results suggest that heavy ion radiation therapy may be 
particularly effective in treating these cancers.
Consistent with previous reports, we also demonstrate that 
telomerase activity is an IR-inducible function. We elaborate 
that in vitro, this phenomenon appears to be peculiar to cell lines 
with high background levels of telomerase activity (e.g., cancer 
and potentially SCs), and further that increased telomerase 
activity appears to be primarily an acute dose response, as LDR 
γ-ray exposures (at least at 1 and 4 Gy cumulative doses) did not 
elevate telomerase activity in the cell lines examined. Importantly, 
however, telomerase activity was elevated in PBMCs post-LDR 
exposure. Expression analysis of the hTERT mRNA and the 
hTERC RNA component of telomerase in MCF-7 cells coincided 
(temporally) with the elevations of telomerase activity, suggesting 
that this process may be transcriptionally regulated. Expression of 
telomerase subunits in MCF-10A cells was dramatically different 
in that both hTERT mRNA and hTERC steadily decreased from 
1 to 5 days postexposure, a finding consistent with the absence 
of significant elevation of telomerase activity in this same time-
frame. It is also important to appreciate, however, that although 
not significant, increases in telomerase activity were observed 
in the non-tumor MCF-10A and normal LCL15044 mammary 
epithelial cell lines following acute IR exposure, indicating that 
telomerase may indeed be induced, but the low background level 
of activity in these cell lines may yield such an increase relatively 
insignificant. Additionally, evaluation of telomerase activity 
in stimulated normal human PBMCs (low background level) 
revealed a significant increase following an acute dose (1  Gy), 
2 days postexposure. Also in contrast to cultured cells, a signifi-
cant increase in telomerase activity was observed in stimulated 
PBMCs 2 and 5 days post-LDR exposure (total 1 Gy delivered 
at a dose rate of 4.9 cGy/h). One potential explanation for this 
could be the more heterogeneous nature of cells in stimulated 
peripheral blood (including stem/progenitor cells) creating a 
disparate signaling environment relative to the more homog-
enous cells found in cultured lines. These findings suggest that 
IR-induced changes in telomerase activity are relevant to LDR 
environmental exposures in  vivo, including those encountered 
during spaceflight. Current investigations in our laboratory are 
testing this hypothesis in astronauts to explore associated changes 
in telomerase activity and telomere length.
As the canonical role of telomerase is to elongate telomeres, 
and reports of changes in telomere length following IR exposure 
are contradictory, suggesting both lengthening and shortening at 
early times postexposure, we evaluated telomere length in divid-
ing MCF-7 and MCF-10A cells at 5 and 10 days postexposure, 
time points more appropriate for the assessment of surviving 
rather than dying cells. Interestingly, at the cell population level, 
telomere length was significantly shortened 5 days postexposure 
in both MCF-7 and MCF-10A cells. While telomere length 
remained significantly shorter than unirradiated controls 10 days 
postexposure, significant lengthening of telomeres occurred as 
compared to 5  days post-IR, despite both cell lines displaying 
significantly decreased telomerase activity during this time 
period. Several studies have shown association between short 
telomeres and radiation sensitivity (52, 55); therefore, we sought 
to determine whether a specific subpopulation of cells, with 
FigUre 9 | Telomerase activity is required for ir-induced enrichment of putative, cD44+/cD24low/− putative mammary stem cell populations. (a) MTT 
assay establishing relative toxicity of the telomerase inhibitor MST-312 in MCF-7 and MCF-10A cells. (B) MST-312 reduced telomerase activity in a dose-dependent 
fashion in both cell lines. Treatment with siRNA targeted to the catalytic subunit hTERT also significantly reduced telomerase activity; siRNA targeted to hTERC did 
not (not shown). (c) Reduction of telomerase activity via either telomerase inhibition (MST-312) or siRNA knockdown (hTERT) prevented IR-induced enrichment of 
CD44+/CD24low/− cell populations 5 days postacute γ-ray exposure (10 Gy).
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relatively short telomeres, was driving the response. Histogram 
analysis of individual telomere lengths demonstrated that all 
of the telomeres in the cell population were shortened and the 
entire distribution of telomere length was shifted monomodally 
to the left; thus, IR was not acting on a specific subset of radiation 
sensitive cells. Furthermore, the observed lengthening between 
days 5 and 10 also shifted the population monomodally indicat-
ing that in the cells surviving exposure, all telomeres are being 
lengthened, not simply preferential elongation of the critically 
short telomeres. These findings portend consequences for both 
carcinogenesis and repopulation of tumor cells following high 
dose radiation therapy in that short telomeres observed at 
5 days could contribute to genomic instability and thus increase 
the propensity for carcinogenic events in surrounding normal 
tissue, as well as the propensity of further progression in of the 
tumor. Furthermore, telomere elongation in the surviving cells 
observed at 5–10 days postexposure strongly suggests a role in the 
survival/repopulation of irradiated cells and so supports blocking 
or manipulating this process as an effective means of preventing 
carcinogenesis and tumor recurrence following radiation therapy.
The suggestions that telomerase appeared to be functioning 
outside of its canonical role at telomeres led us to interrogate 
alternative possibilities for the increases in activity observed 
following exposure. Previous reports have suggested that 
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telomerase activity in NCSCs and CSCs greatly exceeds that of 
their more differentiated counterparts, particularly with regard 
to mammary carcinoma. An accumulating body of evidence 
has begun to amass suggesting that IR induces the enrichment 
of CSC compartments in culture and in  vivo. In addition, this 
process may be governed by the reprograming of NSCC into 
CSC, rather than the selection of radioresistant CSC populations, 
and this phenomenon may be both kinetic and highly regulated. 
Therefore, we speculated that the elevation of telomerase activity 
observed following IR exposure was the result of enriched SC 
populations. A time course of CD44+/CD24low/− putative CSC 
populations in MCF-7 cultures following an acute 10 Gy exposure 
revealed a steady enrichment of CD44+/CD24low/− cells which 
peaked 5 days postexposure but remained significantly elevated 
for at least 7 days. However, no significant enrichment of CD44+/
CD24low/− cells was observed until after 72  h, which occurred 
after the peak of telomerase activity had subsided. Furthermore, 
in MCF-10A cells, a significant, albeit transient, enrichment of 
CD44+/CD24low/− cells was observed 5 days postexposure, with 
only slight increase in telomerase activity at early times following 
exposure. Thus, telomerase activity was not elevated in response to 
CD44+/CD24low/− cell enrichment, but rather preceded it. CD44+/
CD24low/− dose response, clonogenic survival, and growth kinetic 
analysis of MCF-7 and MCF-10A cells following an acute 10 Gy 
exposure was conducted to further characterize the IR-induced 
enrichment of SC populations. The level of CSC enrichment at 
the peak time point of 5 days postexposure was dose dependent 
in MCF-7 with a significant increase detected as low as 2 Gy. In 
contrast, there appeared to be a threshold dose for MCF-10A of 
between 5 and 10 Gy for significant enrichment.
These findings led to a collaborative effort using agent-based 
modeling (ABM) to determine mathematically if the observed 
enrichment in SC compartments following IR exposure resulted 
from the selection of radioresistant SC populations at the time of 
irradiation, or conversely, was a result of reprograming non-stem 
into SCs. Modeling indicated that a significant reprograming 
component must be in place to account for the relative percent-
age enrichment of SC populations (in the <1% of surviving cells) 
5 days postexposure, which occurred in both MCF-7 and MCF-
10A. Furthermore, both reprograming and symmetric division 
of surviving SC populations must be employed to account for the 
observed enrichment (manuscript in preparation, Gao et al.).
In order to confirm that IR-induced reprograming was not 
unique to mammary epithelial cells, we evaluated expression of 
the CD34/CD38 immunophenotype in the hematopoietic cell 
lines KG1a, WTK1, and LCL15044. As WTK1 and LCL15044 are 
terminally differentiated lymphoblastoid lines that express <0.01% 
CD34+ cells at background levels, induction of reprograming was 
assessed using CD34 as the primary marker. In agreement with 
results using mammary epithelial cells, we observed a significant 
enrichment of CD34+ cells in both WTK1 and LCL15044, which 
increased with dose and time, out to 3  days postexposure. SC 
enrichment was again preceded by a general trend toward 
elevated telomerase activity following acute IR exposure, although 
neither WTK1 nor LCL15044 experienced significantly increased 
levels of telomerase activity. Interestingly, the only cell line that 
did not display IR-induced enrichment of CSC was KG1a, a 
therapy-induced leukemia. In this instance, the background level 
of CD34+/CD38− CSCs was significantly decreased in a time- and 
dose-dependent manner following IR exposure. As telomerase 
activity was significantly increased in KG1a cells during this same 
time frame, the results give further credence to our claim that the 
elevation of telomerase activity observed following IR exposure 
is not an artifact of enriched SC/CSC populations. This finding 
is important in that it illustrates IR exposure does not serve to 
increase SC compartments in all situations and may in fact act dif-
ferentially on existing CSC populations, perhaps especially when 
those populations exist at high background levels.
Finally, as increased telomerase activity did not coincide tem-
porally with putative SC enrichment in either MCF-7 or MCF-
10A cells, we hypothesized that telomerase may be playing a role 
to promote IR-induced SC enrichment. To test this hypothesis, we 
employed a small molecule inhibitor (MST-312) as well as siRNA 
knockdown of the catalytic hTERT component of telomerase. Both 
MST-312 and hTERT siRNA significantly reduced telomerase 
activity in both MCF-7 and MCF-10A, and both very effectively 
blocked IR-induced enrichment of CD44+/CD24low/− putative SC 
populations evaluated 5 days post-IR exposure (10 Gy; Figure 9). 
These results convincingly demonstrated that telomerase activity 
is essential for SC enrichment in response to IR exposure and 
so have important implications for radiotherapy, as telomerase 
inhibitors are currently entering Phase III randomized trials in 
humans. When taken together with the observation that although 
elevated post-IR exposure, telomerase activity is not acting to 
elongate telomeres, it becomes clear that telomerase is function-
ing outside its canonical role. Further investigation is needed to 
probe underlying mechanisms, but candidate pathways include 
Wnt/β-catenin signaling, in which hTERT has been shown (albeit 
controversially) to act as a transcriptional coactivator of β-catenin 
target genes important for stemness and dedifferentiation (37, 
39, 41, 100). Additionally, TGF-β signaling has been proposed to 
regulate CSC kinetics in culture and in vivo, and hTERT has also 
been implied as a downstream cotranscriptional regulator (40).
The results presented here serve to highlight and more 
clearly define the critical roles telomeres and telomerase play in 
regulating the radiation response in both normal and cancer cells. 
Specifically, we demonstrated that loss of telomere end-capping 
function results in increased mutation burden and chromosomal 
events that fuel instability; furthermore, this mutation burden 
may be especially elevated in response to high LET radiation, 
particularly in the context of POT1 deficiency. We also establish 
that telomerase is activated by IR exposure, but the extent of such 
elevation is dose, dose rate, and cell type dependent, making 
assessment of risks posed by IR-induced increases in telomerase 
activity complex and requiring further exploration. Third, we 
confirmed and elaborated upon previous findings that acute low 
LET IR exposure enriches putative mammary CSCs in culture 
and expanded these studies to include lymphoblastoid lines, 
which are of great relevance to carcinogenesis and spaceflight risk. 
Lastly, we demonstrated the requirement of telomerase activity in 
promoting IR-induced putative SC enrichment in mammary epi-
thelial cells of both cancer and non-cancer origin, a finding with 
important implications for radiation therapy. Taken together, 
these findings serve to strengthen the view that telomeres and 
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telomerase are far more than casual observers constrained to 
the ends of chromosomes. Rather, they occupy a central role in 
the cellular radiobiological response, governing everything from 
cellular lifespan (aging), cellular plasticity (SCs), and genomic 
integrity (instability), to survivability and carcinogenic potential 
following exposure.
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